Evaluation of anxiety, depression, and quality of life in patients with acne vulgaris, and quality of life in their families  by Duman, Hatice et al.
lable at ScienceDirect
DERMATOLOGICA SINICA 34 (2016) 6e9Contents lists avaiDermatologica Sinica
journal homepage: http: / /www.derm-sinica.comORIGINAL ARTICLEEvaluation of anxiety, depression, and quality of life in patients with
acne vulgaris, and quality of life in their families
Hatice Duman 1, *, Ilteris Oguz Topal 1, Emek Kocaturk 1, Mehmet Ali Duman 2
1 Department of Dermatology, Okmeydani Training and Research Hospital, Istanbul, Turkey
2 Department of Pediatrics, Haseki Training and Research Hospital, Istanbul, Turkeya r t i c l e i n f o
Article history:
Received: Apr 1, 2015
Revised: Jun 28, 2015
Accepted: Jul 11, 2015
Keywords:
acne
anxiety
depression
family
quality of lifeConﬂicts of interest: The authors declare that the
ﬁnancial conﬂicts of interest related to the subject m
in this article.
* Corresponding author. Okmeydanı Egitim ve A
Zührevi Hastalıklar Klinigi, Darülaceze Caddesi, S¸is¸li,
E-mail address: hatice-ergun15@hotmail.com (H.
http://dx.doi.org/10.1016/j.dsi.2015.07.002
1027-8117/Copyright © 2015, Taiwanese Dermatolog
(http://creativecommons.org/licenses/by-nc-nd/4.0/)a b s t r a c t
Background/Objectives: Dermatological diseases not only affect patients' lives but also the lives of their
family members. Our aim was to evaluate anxiety and depression risk in patients with acne vulgaris and
the effect of acne vulgaris on quality of life of the patients and their families.
Methods: A total of 125 patients with acne vulgaris, 110 of their family members, and 100 healthy vol-
unteers were included in the study. Patients with acne vulgaris were requested to complete the Acne
Quality of Life Scale (AQOL) and Hospital Anxiety and Depression Scale (HAD) at the time of the ﬁrst
admission and 2 months later. The healthy volunteers were only asked to complete the HAD, and the
family members ﬁlled out the Family Dermatology Life Quality Index (FDLQI) at the time of the ﬁrst
admission and 2 months later.
Results: The acne and control groups showed no signiﬁcant differences between the HAD anxiety sub-
scale (HAD-A) and HAD depression subscale (HAD-D) scores. The mean AQOL score of the patients was
6.8 ± 5.3. AQOL scores were positively correlated with HAD-A, HAD-D and FDLQI scores. The mean score
of the FDLQI was 7.6 ± 5.3. FDLQI scores showed a statistically signiﬁcant change after 2 months
(p ¼ 0.001).
Conclusion: Acne vulgaris does not have an effect on quality of life and the risk of anxiety or depression.
In the cases of acne, when the quality of life decreases, the risk of depression as well as anxiety increases
and the quality of life of the family members is negatively affected. Acne vulgaris negatively affects the
quality of life of the family members of the patients.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Acne vulgaris, affecting mostly adolescents and young adults, is a
chronic inﬂammatory disease of the pilosebaceous unit. Involving
particularly the face, which has a great impact on visual appear-
ance, acne can affect emotional, social, and psychological functions,
as well as the patient's quality of life. In this study, the impact on
quality of life and the prevalence of anxiety and depression were
evaluated by analysis of a number of questionnaires completed by
acne vulgaris patients.1,2y have no ﬁnancial or non-
atter or materials discussed
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.The close family members of patients with dermatological
problems also experience some social, physical, and psychological
problems. Therefore, it is prudent to determine and to increase the
quality of life of the patients and their family members.3
The aim of this study was to evaluate the risk of anxiety and
depression in acne vulgaris patients and to determine the impact of
the disease on the quality of life of the patients and their close
family members.
Materials and methods
A total of 125 patients with acne vulgaris who attended the
outpatient clinic of the Department of Dermatology at Okmeydani
Education and Research Hospital, Istanbul, Turkey, between August
2013 and May 2014, who had no other dermatologic or psychiatric
diseases, and who had no treatment for the previous 6 months,
were included in the study, as well as 110 of their family membersevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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ﬁrst-degree relative or spouse). Patients solely having body
involvement were excluded. The age, sex, duration of the disease,
previous treatments, and acne severity of the patients were
recorded. The age, sex, educational status, and monthly income of
the family members were also recorded.
To assess the quality of life of the patients, a Turkish version of
the Acne Quality of Life Scale (AQOL) was used, and to determine
the risk of anxiety and depression, a Turkish version of the Hospital
Anxiety and Depression Scale (HAD) was used.4e7 To evaluate the
impact of acne vulgaris on the quality of life of the family members,
a Turkish version of the Family Dermatology Life Quality Index
(FDLQI) was used.8,9 The AQOL consists of nine items, all of which
are scored on a 4-point scale, with 0 meaning ‘not at all’ and 3
meaning ‘very markedly.’ The total score was calculated by sum-
ming the scores for each item; higher scores indicated a negative
impact on quality of life.4 The HAD contains 14 items: seven related
to anxiety and seven to depression. In the Turkish version of the
scale, the cut-off score was found to be 10 for the anxiety subscale
(HAD-A) and 7 for the depression subscale (HAD-D).7 The FDLQI is a
dermatology-speciﬁc quality of life scale for the family members of
patients having any skin disease. It has 10 items, with each item
scored from 0 to 3, and higher scores indicate greater impairment
of quality of life.8
To determine the acne severity, the Global Acne Grading scale
was used. The total score was evaluated accordingly: mild (1e18),
moderate (19e30), severe (31e38), and very severe (>38). Because
patients having a very severe form of the disease were very few in
number, they were recruited into the ‘severe’ group.10
Family members were grouped into ﬁve categories accordingly:
literate, elementary school, middle school, high school, college.
They were also grouped according to their monthly incomes into
four groups: 1000 Turkish Liras, 1001e2000 Turkish Liras,
2001e3000 Turkish Liras, and 3001 Turkish Liras.
One hundred age-, sex-, and educationally-matched healthy
volunteers (middleehigh school students and personnel of the
hospital) without a dermatologic or systemic disease were
recruited into the control group. Because the AQOL scale is a
disease-speciﬁc test, healthy volunteers were asked to complete
only the HAD. To determine the impact of the therapy on the quality
of life of acne patients and their family members, as well as the risk
of anxiety and depression of the acne patients, the same ques-
tionnaires were applied 2 months later.
The study protocol was approved by the ethics committee of our
hospital. Written and signed informed consent was obtained from
the family members and the patients or the legal guardians.
For the descriptive analysis of the data, mean, median, standard
deviation, minimumemaximum, and frequency values were used.
Distribution of the parameters was controlled using the Kolmo-
goroveSmirnov test. Quantitative values were analyzed using an
independent t test, KruskaleWallis test, andManneWhitney U test.
Qualitative values were analyzed using a chi-square test. A corre-
lation analysis was performed using Spearman's correlation
analysis.
Results
Of the 125 patients, 53 were male and 72 were female. The mean
agewas 18.1± 3.3 years (minemax; 14e35 years) and themean age
at disease onset was 14 ± 1.9 years (minemax; 9e22 years). The
mean disease durationwas 46.06 ± 39.7months (minemax; 2e294
months). The control group consisted of 39 male and 61 female
participants, and the mean age was 18 ± 3.8 years (minemax;
14e30 years). The FDLQI was ﬁlled out by 110 subjects (94 female,
16 male), whose mean age was 41.9 ± 8.7 years (minemax; 19e67years). In total, 85 family members were mothers (77.3%), 13 were
fathers (11.8%), 9 were siblings (8.2%), and 3 were spouses (2.7%).
Fifty-nine patients (47.2%) had previously received therapy: 35
(28%) topical therapy; 23 (18.4%) systemic antibiotic and topical
therapy; and 1 (0.8%) systemic isotretinoin therapy. The percentage
of patients with mild acne was 17.6% (n ¼ 22), 56% (n ¼ 70) had
moderate acne, 25.6% (n¼ 32) had severe acne, and 0.8% (n¼ 1) had
very severe acne.
The mean AQOL score of the patients was 6.8 ± 5.3 (minemax;
0e25). There were no statistically signiﬁcant differences between
the control and the patient groups with respect to age, sex, and
HAD-A and HAD-D scores (p > 0.05); however, according to the cut-
off point, HAD-D had a higher patient rate in the control group than
in the patient group (p ¼ 0.021; Table 1). There were no signiﬁcant
differences between males and females with regard to AQOL, HAD-
A, and HAD-D scores (p > 0.05).
Where the relationship between AQOL and HADwas concerned,
AQOL scores were positively correlated with HAD-A and HAD-D
scores (p < 0.001, r ¼ 0.468; p < 0.001, r ¼ 0.492, respectively).
No signiﬁcant relationships were found between age, age at
disease onset, disease duration or acne severity, and AQOL, HAD-A,
or HAD-D scores (p > 0.05). When the patients with acne were
grouped according to the cut-off point of HAD-A and HAD-D, we
found no differences between scores with regard to severity of acne
(p > 0.05).
Therewere no relationships between the previous therapies and
AQOL, HAD-A or HAD-D scores (p > 0.05).
Two months later, 41 patients attended a second evaluation.
Following therapy, acne severity showed a signiﬁcant reduction in
the 41 patients (p < 0.001). However, at the end of the 2nd month,
the AQOL, HAD-A, and HAD-D scores of the 41 patients did not
change compared with the baseline. When the patients with acne
were grouped according to the cut-off point of HAD-A and HAD-D,
the rate of 41 patients at risk of anxiety and depression did not
change at the end of the 2nd month compared with the baseline
(p > 0.05; Table 2).
The mean score of the FDLQI was 7.6 ± 5.3 (minemax; 0e23). In
total, 30 family members attended a second evaluation and their
mean FDLQI score was 8.4 ± 5.6 at the baseline and the mean FDLQI
score was 4.9 ± 4.0 at the end of the 2nd month; the change was
statistically signiﬁcant (p ¼ 0.001; Table 2).
The FDLQI scores showed no signiﬁcant difference according to
sex, age, relationship with patients, educational status, monthly
income, or acne severity (p > 0.05).
A positive correlation was found between the FDLQI and AQOL
scores (p ¼ 0.034, r ¼ 0.202).
Discussion
By contrast with most other systems, dermatologic disorders are
not life threatening; instead, they alter the appearance of the pa-
tient and may therefore affect one's psychosocial status, relation-
ships, daily activities, and quality of life as much as severe systemic
diseases, regardless of the clinical severity of the dermatologic
disorders.1,2,11 In particular, in patients with acne vulgaris, the risk
of anxiety and depression, and therefore suicidal tendencies, is said
to be increased. Furthermore, difﬁculties in social, occupational,
and academic ﬁelds have been observed, although some different
results have been recorded in various research studies.1,12
Some studies reported an increased risk of anxiety and
depression in acne vulgaris patients accompanied by an impair-
ment of quality of life in comparison with healthy individuals,
although some studies showed no difference.13e20 In this study, we
evaluated the quality of life with an acne-speciﬁc index, the AQOL,
in acne vulgaris patients, which demonstrated a decreased mean
Table 1 Comparison of the test results of acne patients and the control group.
Patients, n ¼ 125 Control group, n ¼ 100 p
HAD-A 8.1 ± 4.0 9.0 ± 4.4 0.201
HAD-D 5.8 ± 3.6 6.9 ± 4.2 0.053
Anxiety subscale >10 35 (28) 28 (28) 1
Depression subscale >7 33 (26.4) 41 (41) 0.021
Data are presented as mean ± standard deviation or n (%).
HAD-A ¼ Hospital Anxiety and Depression Scale-Anxiety Subscale; HAD-D ¼ Hospital Anxiety and Depression Scale-Depression Subscale.
Table 2 Comparison of the test results according to therapy.
Baseline 3rd mo of treatment p
AQOLa 7.0 ± 6.0 5.8 ± 4.8 0.136
HAD-Aa 8.8 ± 4.0 8.5 ± 3.9 0.757
HAD-Da 5.9 ± 3.9 5.7 ± 4.5 0.308
Anxiety subscale >10a 13 (31.7) 14 (34.1) 1
Depression subscale >7a 11 (26.8) 15 (36.6) 0.219
FLDQIb 8.4 ± 5.6 4.9 ± 4 <0.001
Data are presented as mean ± standard deviation or n (%).
AQOL ¼ Acne Quality of Life Scale; FLDQI ¼ Family Dermatology Life Quality Index; HAD-A ¼ Hospital Anxiety and Depression Scale-Anxiety Subscale; HAD-
D ¼ Hospital Anxiety and Depression Scale-Depression Subscale.
a Forty-one of the patients attended for second evaluation
b Thirty family members attended for second evaluation.
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of anxiety or depression in acne vulgaris patients.
Furthermore, in previous studies, it was shown that quality of
life was increased and the risk of anxiety and depression was
decreased by suitable acne therapies, which also showed that acne
affects patients in psychosocial ways.21,22 In our study, we did not
show any statistically signiﬁcant changes in the AQOL, HAD-A, and
HAD-D scores at the end of the 2nd month of therapy compared
with the baseline. This may be due to an inadequate number of
patients who attended a second evaluation, or an incomplete res-
olution of the symptoms in 2 months.
There was no relationship between acne severity and HAD-A or
HAD-D scores, and many other studies were consistent with
ours.13,18,20 However, in a study by Erdemir et al,18 the acne severity
was not only deﬁned by the physicians, but also deﬁned by the
patients, which showed a positive correlation with HAD-A and
HAD-D scores. Perception of acne severity may differ from physi-
cian to patient. Because the risk of anxiety and depression is
correlated to patients' perceptions of their disease, we should
consider this data in evaluation of the patients. In our study, acne
severity was deﬁned only by physicians, and this might have
affected our ﬁndings. In the same manner, although some studies
demonstrated that the severity of the disease had a negative effect
on quality of life, some did not show any signiﬁcant
correlation.13e15,18,23 In our study, there was no signiﬁcant relation
between AQOL scores and acne severity.
In the relationship between sex and AQOL, HAD-A and HAD-D
scores were not signiﬁcant. Although some studies showed
similar ﬁndings, some studies also demonstrated a greater risk of
anxiety and a greater impairment of quality of life inwomen than in
men with acne vulgaris.14,15,18,20,22e24
We also did not ﬁnd relationships between age, duration of the
disease, or previous therapies and AQOL, HAD-A, or HAD-D scores.
These results were consistent with most of the literature.14,15,23,24
However, Tan et al17 reported the quality of life in acne patients
of an older age, with a disease duration of >5 years, was negatively
affected.
We demonstrated a positive correlation between AQOL scores
and HAD-A and HAD-D scores. Therefore, a greater impairment of
quality of life due to acne leads to an increased risk of anxiety ordepression. Yazici et al13 and Erdemir et al18 also reported a similar
correlation and attributed it to patients' perceptions of their dis-
ease. This shows the importance of evaluating patients with psy-
chological and quality of life questionnaires, instead of just one.
Recently, it was shown that dermatologic diseases not only
affect patients' lives but also their families in many ways; therefore,
studies have been performed to evaluate the effect of the diseases
on the quality of life of the family members. These studies evalu-
ating the effect of chronic dermatoses on quality of life of family
members were limited to atopic dermatitis and psoriasis.3 In a
study performed by Basra et al25 with a group of family members
who had close relatives with psoriasis, acne, eczema, melanoma,
and some other benign and malign dermatologic diseases, the
mean FDLQI score was found to be 6.0. In a study by Basra et al8 in
which the FDLQI was improved, the mean FDLQI score of the whole
group of patients was 8.02, and in the acne group, it was 8.9 which
was found to be the second highest score after the eczema group.
For the family members of vitiligo patients, the mean FDLQI score
was 10.3 and it was shown that the disease signiﬁcantly affected
the family members.26 In the literature, we did not ﬁnd any study
performed speciﬁcally to evaluate the quality of life in the family
members of acne vulgaris patients. In our study, the mean FDLQI
was found to be 7.6. For the family members who attended the
second evaluation, the ﬁrst mean FDLQI score was 8.4 and after 2
months, the mean score for the same subgroup was 4.9; the change
was statistically signiﬁcant. This result shows the family members
of the acne patients are affected by the disease. Moreover, Basra
et al8 reported the quality of life score in familymembers correlated
with the progression of the disease. We found that quality of life in
familymembers was negatively affected. In our study, patients with
acne vulgaris were mostly high school students and the family
members were mostly mothers, probably due to the fact that in our
country, a high rate of women are housewives and their main duty
is to look after their children. Women are usually more emotional
than men, and this might have affected our result.
In our study, there was not a signiﬁcant correlation between the
severity of the acne and the FDLQI scores. However, Sampogna
et al27 and Basra et al8 reported the quality of life of the family
members was correlated with the severity of other skin disorders.
Sampogna et al27 investigated dystrophic epidermolysis bullosa
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very severe condition and always requires much care. Basra et al8
investigated 21 different dermatologic diseases, such as psoriasis,
acne, eczema, melanoma, and some other benign and malign
dermatologic disorders. They used a subjective assessment of the
patients' disease severity. As we have mentioned before, we used a
physician-rated scale to assess acne severity.
In our study, a positive correlation was reported between the
AQOL and FDLQI scores. In the literature, there are studies with
similar results.8,25,26 This ﬁnding shows that the greater impair-
ment of the patient's quality of life, regardless of disease severity,
also negatively affected the family members' quality of life. We
consider also that the unhappiness and hopelessness of a family
member might negatively affect the other family members. Despite
the acne severity, a positive correlation with AQOL and FDLQI
scores shows us again the importance of patients' perceptions of
their disease.
Consistent with our study, some studies did not show a signif-
icant difference in quality of life scores of family members with
regard to the degree of relationship or sex.8,25,27 However, Bin Saif
et al26 reported higher FDLQI scores in male family members.
Basra et al8 reported signiﬁcantly higher quality of life scores in
the family members who are aged <12 years. In our study, there
was no correlation between age and FDLQI scores.
In the study on vitiligo patients and their family members, the
FDLQI scores were signiﬁcantly higher in thosewith shorter disease
duration and in the family members with higher incomes.26 In our
study, therewere no signiﬁcant relationships between FDLQI scores
and the duration of the disease, educational status, or monthly
income. No signiﬁcant relationship was found between marital
status and quality of life, and the data of Basra et al25 were
consistent with ours.
There are several limitations to our study. First, the number of
mothers is higher in our family group. This could have affected the
FDLQI scores. Second, an inadequate number of patients and family
members attended the second evaluation. This could have affected
a clear evaluation of quality of life in patients and family members.
Acne vulgaris does not affect quality of life and the risk of
anxiety and depression. The severity and the duration of the dis-
ease, sex, age, and any previous therapies does not affect quality of
life and the risk of anxiety and depression. In acne patients, when
quality of life decreases, the risk of anxiety and depression in-
creases. Therefore, it is necessary to evaluate acne patients both
with psychological assays and with quality of life questionnaires, as
well as to work synchronously with psychiatry. In the families of
the acne patients, the family members' quality of life appears to be
affected. The quality of life in family members is not affected by sex,
age, educational and marital status, monthly income, or disease
severity. As the quality of life in acne patients decreases, the quality
of life in family members also appears to be decreased. It is
important to remember dermatologic disorders not only affect the
patients, but also the people with whom they are in close re-
lationships with; therefore, the patient and his or her family must
be evaluated as a whole. According to our results, to evaluate the
effect of therapy and of the disease on patients' quality of life, the
quality of life of family members, and the risk of anxiety and
depression, we recommend an evaluation of all of the patients and
the family members prior to and following therapy.References
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